Fundamental Analysis of COMPASS PATHWAYS PLC(NASDAQ:CMPS) stock

Fundamental Rating

Overall CMPS gets a fundamental rating of 1 out of 10. We evaluated CMPS against 564 industry peers in the Biotechnology industry. CMPS has a bad profitability rating. Also its financial health evaluation is rather negative. CMPS does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CMPS has reported negative net income.

CMPS had a negative operating cash flow in the past year.

In the past 5 years CMPS always reported negative net income.

CMPS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

CMPS has a Return On Assets of -58.35%. This is comparable to the rest of the industry: CMPS outperforms 42.19% of its industry peers.

CMPS has a Return On Equity (-74.77%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-58.35%
ROE	-74.77%
ROIC	N/A

ROA(3y)-37.72%

ROA(5y)-40.66%

ROE(3y)-42.73%

ROE(5y)-77.91%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CMPS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for CMPS has been increased compared to 1 year ago.

CMPS has more shares outstanding than it did 5 years ago.

The debt/assets ratio for CMPS is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.10, we must say that CMPS is in the distress zone and has some risk of bankruptcy.

CMPS has a Altman-Z score (-1.10) which is in line with its industry peers.

A Debt/Equity ratio of 0.14 indicates that CMPS is not too dependend on debt financing.

CMPS has a worse Debt to Equity ratio (0.14) than 66.97% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	N/A
Altman-Z	-1.1

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 8.91 indicates that CMPS has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 8.91, CMPS is in the better half of the industry, outperforming 76.66% of the companies in the same industry.

CMPS has a Quick Ratio of 8.91. This indicates that CMPS is financially healthy and has no problem in meeting its short term obligations.

CMPS has a better Quick ratio (8.91) than 77.02% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.91
Quick Ratio	8.91

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.06% over the past year.

EPS 1Y (TTM)15.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%16.42%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CMPS will show a small growth in Earnings Per Share. The EPS will grow by 1.99% on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-0.98%

EPS Next 2Y5.98%

EPS Next 3Y5.14%

EPS Next 5Y1.99%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMPS. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMPS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y5.98%

EPS Next 3Y5.14%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CMPS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

COMPASS PATHWAYS PLC

NASDAQ:CMPS (1/2/2025, 8:21:06 PM)

After market: 4.209 +0.06 (+1.42%)

4.15

+0.37 (+9.79%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)10-31 2024-10-31/bmo

Earnings (Next)N/A N/A

Inst Owners42.08%

Inst Owner Change15.37%

Ins Owners2.49%

Ins Owner Change-23.2%

Market Cap283.95M

Analysts83.75

Price Target21.65 (421.69%)

Short Float %7.27%

Short Ratio3.88

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-0.48%

Min EPS beat(2)-4.82%

Max EPS beat(2)3.87%

EPS beat(4)1

Avg EPS beat(4)-17.34%

Min EPS beat(4)-57.46%

Max EPS beat(4)3.87%

EPS beat(8)3

Avg EPS beat(8)-13.77%

EPS beat(12)6

Avg EPS beat(12)-4.1%

EPS beat(16)9

Avg EPS beat(16)1.81%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-44.48%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-13.41%

EPS NY rev (1m)-2.23%

EPS NY rev (3m)-2.2%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	1.47
P/tB	1.47
EV/EBITDA	N/A

EPS(TTM)-2.2

EYN/A

EPS(NY)-2.1

Fwd EYN/A

FCF(TTM)-1.54

FCFYN/A

OCF(TTM)-1.54

OCFYN/A

SpS0

BVpS2.82

TBVpS2.82

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-58.35%
ROE	-74.77%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-37.72%

ROA(5y)-40.66%

ROE(3y)-42.73%

ROE(5y)-77.91%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	4.71%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	8.91
Quick Ratio	8.91
Altman-Z	-1.1

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)130.81%

Cap/Depr(5y)158.79%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)15.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%16.42%

EPS Next Y-0.98%

EPS Next 2Y5.98%

EPS Next 3Y5.14%

EPS Next 5Y1.99%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-35.49%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-35.25%

EBIT Next 3Y-14.5%

EBIT Next 5Y1.05%

FCF growth 1Y-26.61%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-27.5%

OCF growth 3YN/A

OCF growth 5YN/A

COMPASS PATHWAYS PLC (CMPS)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens